{"id":"clm_EAEA070624D5","entity":"regeneron-pharmaceuticals","predicate":"shares_outstanding","value":"89,499,900 shares","value_json":{"fp":"Q2","fy":2011,"accn":"0001206774-11-001639","form":"10-Q","filed":"2011-07-28","period":"Q2 FY2011","concept":"dei:EntityCommonStockSharesOutstanding"},"valid_from":"2011-07-15","valid_to":"2011-10-19","published":"2011-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Regeneron Pharmaceuticals shares outstanding: 89,499,900 shares\", as of 2011-07-15 (until 2011-10-19). Claim clm_EAEA070624D5, https://asof.is/claim/clm_EAEA070624D5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm.","url":"https://asof.is/claim/clm_EAEA070624D5","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1AE57BD8CE95","supersedes":["clm_4A8E4990BE56"],"first_seen_at":"2026-11-08T17:08:55.512322+00:00","updated_at":"2026-11-08T17:09:02.679946+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/872589/000120677411001639/0001206774-11-001639-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2011","published_at":"2011-07-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2011, filed 2011-07-28"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}